Sanaria
Sanaria

Research & Development Plan

Sanaria's primary current research and development goals are to achieve licensure, commercialization and deployment of a PfSPZ-based vaccine as soon as possible. A vaccine development plan, clinical development plan, and regulatory and commercialization strategy are in place and Sanaria is proceeding systematically to achieve these goals during the next few years. Post-licensure Sanaria's R&D efforts will focus on widespread deployment and increasing the usefulness and penetration of PfSPZ-based vaccines worldwide by increasing the level and duration of protective efficacy against all malaria, reducing the numbers of doses of vaccine required, reducing the time required to complete an immunization regimen, and decreasing the costs of immunization. The ultimate goal is to be able to be use PfSPZ-based vaccines to immunize the entire population in geographically defined areas so as to halt malaria transmission and thereby eliminate malaria.

 

disclaimer     site map

copyright(c) 2003-2018, Sanaria Inc., all rights reserved